Intra-DG injection of IL-1β abolished the therapeutic effect of COS on AHN deficits induced by CRS, suggesting that microglia-derived IL-1β in the DG functioned as the key mediators for promoting AHN by COS. The gene discussed is IL1B; the disease is congenital rubella syndrome.